• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cancer and the tumor microenvironment: a review of an essential relationship.癌症与肿瘤微环境:对一种重要关系的综述
Cancer Chemother Pharmacol. 2009 Mar;63(4):571-82. doi: 10.1007/s00280-008-0881-9. Epub 2008 Dec 14.
2
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解:肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
3
Stromal contributions to the carcinogenic process.基质对致癌过程的作用。
Mol Carcinog. 2017 Apr;56(4):1199-1213. doi: 10.1002/mc.22583. Epub 2016 Nov 5.
4
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.全面剖析癌症生物学:解析肿瘤微环境,以实现肿瘤学临床的有效癌症治疗。
OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13.
5
What's new about the tumor microenvironment of urothelial carcinoma?尿路上皮癌肿瘤微环境有哪些新特点?
Clin Transl Oncol. 2024 Jul;26(7):1549-1560. doi: 10.1007/s12094-024-03384-w. Epub 2024 Feb 8.
6
The metastatic niche and stromal progression.转移灶微环境和基质进展。
Cancer Metastasis Rev. 2012 Dec;31(3-4):429-40. doi: 10.1007/s10555-012-9373-9.
7
Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.对抗这种力量:同源框基因对肿瘤微环境的调控潜力
Biochim Biophys Acta. 2015 Apr;1855(2):248-53. doi: 10.1016/j.bbcan.2015.03.004. Epub 2015 Mar 24.
8
[The metastatic process: history, models and recent advances].[转移过程:历史、模型与最新进展]
Med Sci (Paris). 2012 Jan;28(1):89-95. doi: 10.1051/medsci/2012281022. Epub 2012 Jan 27.
9
Key participants of the tumor microenvironment of the prostate: an approach of the structural dynamic of cellular elements and extracellular matrix components during epithelial-stromal transition.前列腺肿瘤微环境的关键参与者:上皮-间质转化过程中细胞成分和细胞外基质成分的结构动态研究方法
Acta Histochem. 2015 Jan;117(1):4-13. doi: 10.1016/j.acthis.2014.10.009. Epub 2014 Nov 20.
10
Targeting angiogenesis and the tumor microenvironment.靶向血管生成与肿瘤微环境。
Surg Oncol Clin N Am. 2013 Oct;22(4):629-39. doi: 10.1016/j.soc.2013.06.002. Epub 2013 Jul 26.

引用本文的文献

1
Adipose-Derived Exosomes: mediators of crosstalk between Adipose tissue and cancer.脂肪来源的外泌体:脂肪组织与癌症之间相互作用的介质
Cancer Biol Ther. 2025 Dec;26(1):2547564. doi: 10.1080/15384047.2025.2547564. Epub 2025 Aug 16.
2
Research progress on new physical therapies for cancer (Review).癌症新物理疗法的研究进展(综述)
Oncol Lett. 2025 Apr 25;29(6):313. doi: 10.3892/ol.2025.15059. eCollection 2025 Jun.
3
Three-dimensional in vitro models in head and neck cancer: current trends and applications.头颈部癌症的三维体外模型:当前趋势与应用
Med Oncol. 2025 May 5;42(6):194. doi: 10.1007/s12032-025-02737-x.
4
The role of tumor microenvironment and self-organization in cancer progression: Key insights for therapeutic development.肿瘤微环境和自组织在癌症进展中的作用:治疗开发的关键见解。
Bioimpacts. 2024 Dec 7;15:30713. doi: 10.34172/bi.30713. eCollection 2025.
5
Biotechnology-assisted cancer therapy using metal sulfides based on their optical and thermophysical properties.基于金属硫化物的光学和热物理性质的生物技术辅助癌症治疗。
Nanoscale Adv. 2025 Mar 21;7(10):2773-2795. doi: 10.1039/d4na00929k. eCollection 2025 May 13.
6
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies.探索肺癌微环境:信号通路与基于纳米颗粒的疗法。
Discov Oncol. 2025 Feb 11;16(1):159. doi: 10.1007/s12672-025-01902-y.
7
Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.生物材料界面与药物递送的最新进展:挑战、创新及未来展望。
Z Naturforsch C J Biosci. 2024 Nov 21. doi: 10.1515/znc-2024-0208.
8
DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment.DeSide:一种用于肿瘤微环境细胞去卷积的统一深度学习方法。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2407096121. doi: 10.1073/pnas.2407096121. Epub 2024 Nov 8.
9
Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells.用于向肿瘤细胞深度递送化疗药物的双阶段作用树枝状纳米颗粒。
Adv Pharm Bull. 2024 Oct;14(3):634-645. doi: 10.34172/apb.2024.054. Epub 2024 Jun 29.
10
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape.替波替尼治疗下 METex14 改变的非小细胞肺癌的空间分析:改变免疫抑制景观。
Neoplasia. 2024 Nov;57:101063. doi: 10.1016/j.neo.2024.101063. Epub 2024 Oct 3.

本文引用的文献

1
Precision proteomics: the case for high resolution and high mass accuracy.精准蛋白质组学:高分辨率和高质量精度的实例
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18132-8. doi: 10.1073/pnas.0800788105. Epub 2008 Sep 25.
2
Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.使用液相色谱-串联质谱法(LC-MS/MS)在代表乳腺癌进展的同基因细胞系中鉴定差异分泌的生物标志物。
J Proteome Res. 2007 Aug;6(8):2993-3002. doi: 10.1021/pr060629m. Epub 2007 Jul 4.
3
Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.从葡萄膜黑色素瘤分泌蛋白组中发现生物标志物:患者血清中gp100和组织蛋白酶D的鉴定
J Proteome Res. 2007 Jul;6(7):2802-11. doi: 10.1021/pr070021t. Epub 2007 Jun 1.
4
Thrombin-cleaved COOH(-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells.凝血酶切割的COOH(-)末端骨桥蛋白肽在小鼠乳腺癌细胞中与亲环蛋白C结合至CD147。
Cancer Res. 2007 May 1;67(9):4088-97. doi: 10.1158/0008-5472.CAN-06-4066.
5
Toward a better analysis of secreted proteins: the example of the myeloid cells secretome.迈向对分泌蛋白的更好分析:以髓样细胞分泌组为例。
Proteomics. 2007 Jun;7(11):1757-70. doi: 10.1002/pmic.200601024.
6
The tumour microenvironment as a target for chemoprevention.作为化学预防靶点的肿瘤微环境
Nat Rev Cancer. 2007 Feb;7(2):139-47. doi: 10.1038/nrc2067.
7
The regulation and role of osteopontin in malignant transformation and cancer.骨桥蛋白在恶性转化和癌症中的调控及作用
Cytokine Growth Factor Rev. 2006 Dec;17(6):463-74. doi: 10.1016/j.cytogfr.2006.09.010. Epub 2006 Nov 17.
8
A Standard Operating Procedure (SOP) for the preparation of intra- and extracellular proteins of Clostridium acetobutylicum for proteome analysis.用于丙酮丁醇梭菌细胞内和细胞外蛋白质制备以进行蛋白质组分析的标准操作规程(SOP)。
J Microbiol Methods. 2007 Feb;68(2):396-402. doi: 10.1016/j.mimet.2006.09.018. Epub 2006 Nov 13.
9
Proteomic identification of the wt-p53-regulated tumor cell secretome.野生型p53调控的肿瘤细胞分泌蛋白质组的鉴定
Oncogene. 2006 Dec 7;25(58):7650-61. doi: 10.1038/sj.onc.1209969. Epub 2006 Oct 9.
10
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.组织转谷氨酰胺酶的表达促进乳腺癌细胞的黏附、侵袭和存活。
Oncogene. 2007 Apr 12;26(17):2459-70. doi: 10.1038/sj.onc.1210035. Epub 2006 Oct 16.

癌症与肿瘤微环境:对一种重要关系的综述

Cancer and the tumor microenvironment: a review of an essential relationship.

作者信息

Mbeunkui Flaubert, Johann Donald J

机构信息

Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695, USA.

出版信息

Cancer Chemother Pharmacol. 2009 Mar;63(4):571-82. doi: 10.1007/s00280-008-0881-9. Epub 2008 Dec 14.

DOI:10.1007/s00280-008-0881-9
PMID:19083000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2858592/
Abstract

PURPOSE

The role of the microenvironment during the initiation and progression of carcinogenesis is now realized to be of critical importance, both for enhanced understanding of fundamental cancer biology, as well as exploiting this source of relatively new knowledge for improved molecular diagnostics and therapeutics.

METHODS

This review focuses on: (1) the approaches of preparing and analyzing secreted proteins, (2) the contribution of tumor microenvironment elements in cancer, and (3) the potential molecular targets for cancer therapy.

RESULTS

The microenvironment of a tumor is an integral part of its physiology, structure, and function. It is an essential aspect of the tumor proper, since it supplies a nurturing environment for the malignant process. A fundamental deranged relationship between tumor and stromal cells is essential for tumor cell growth, progression, and development of life threatening metastasis. Improved understanding of this interaction may provide new and valuable clinical targets for cancer management, as well as risk assessment and prevention. Non-malignant cells and secreted proteins from tumor and stromal cells are active participants in cancer progression.

CONCLUSIONS

Monitoring the change in the tumor microenvironment via molecular and cellular profiles as tumor progresses would be vital for identifying cell or protein targets for cancer prevention and therapy.

摘要

目的

现在人们认识到,微环境在致癌作用的起始和进展过程中所起的作用至关重要,这对于增进对癌症基础生物学的理解,以及利用这一相对新知识来源改善分子诊断和治疗均具有重要意义。

方法

本综述重点关注:(1)分泌蛋白的制备和分析方法,(2)肿瘤微环境要素在癌症中的作用,以及(3)癌症治疗的潜在分子靶点。

结果

肿瘤的微环境是其生理、结构和功能不可或缺的一部分。它是肿瘤本身的一个重要方面,因为它为恶性过程提供了一个滋养环境。肿瘤细胞与基质细胞之间根本的紊乱关系对于肿瘤细胞的生长、进展以及危及生命的转移的发生至关重要。对这种相互作用的深入理解可能为癌症管理以及风险评估和预防提供新的、有价值的临床靶点。肿瘤和基质细胞中的非恶性细胞及分泌蛋白是癌症进展的积极参与者。

结论

随着肿瘤进展,通过分子和细胞特征监测肿瘤微环境的变化对于确定癌症预防和治疗的细胞或蛋白质靶点至关重要。